UNITE4TB: a new consortium for clinical drug and regimen development for TB.
M J Boeree, C Lange, G Thwaites, N Paton, R de Vrueh, D Barros, M Hoelscher
Author Information
- M J Boeree: Lung Diseases, Radboud University Medical Center, Nijmegen, The Netherlands.
- C Lange: Clinical Infectious Diseases, Research Center Borstel, Borstel, Germany.
- G Thwaites: Clinical Research Unit, Hospital for Tropical Diseases, Oxford University, Oxford, UK.
- N Paton: Global Health Portfolio.
- R de Vrueh: Lygature, Utrecht, The Netherlands.
- D Barros: Global Health, GSK, Brentford, UK.
- M Hoelscher: Department of Infectious Diseases and Tropical Medicine, Munich, Germany.
No abstract text available.
- Adv Drug Deliv Rev. 2016 Jul 1;102:116-22
[PMID: 26827911]
- N Engl J Med. 2021 May 6;384(18):1705-1718
[PMID: 33951360]
- N Engl J Med. 2014 Oct 23;371(17):1599-608
[PMID: 25337749]
- PLoS Med. 2020 Feb 27;17(2):e1003059
[PMID: 32106220]
- PLoS Med. 2019 Jul 9;16(7):e1002851
[PMID: 31287813]
- N Engl J Med. 2014 Oct 23;371(17):1577-87
[PMID: 25196020]
- N Engl J Med. 2014 Oct 23;371(17):1588-98
[PMID: 25337748]
- N Engl J Med. 2012 Jun 7;366(23):2151-60
[PMID: 22670901]
- N Engl J Med. 2020 Mar 5;382(10):959-960
[PMID: 32130819]
- BMC Med. 2016 Mar 23;14:51
[PMID: 27004726]
Antitubercular Agents
Clinical Protocols
Humans
Pharmaceutical Preparations
Tuberculosis, Multidrug-Resistant
Antitubercular Agents
Pharmaceutical Preparations
